Topics

Jacobs School event was held in memory of Tops massacre victim Pearl Young.

“The Future of Health” — a forward-looking report jointly released today by the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo and the Jacobs Institute — heralds massive potential for improving health care in the United States.

Organized in response to the Supreme Court's decision to overturn Roe v. Wade, the conference will be a dialogue between academics and the community.

Thirty-two faculty members with a variety of clinical and research experience — representing 12 medical school departments — have joined the Jacobs School of Medicine and Biomedical Sciences over the past several months.

The free, student-managed clinic of UB’s health sciences units is now offering dental care, thanks to a CTSI seed grant.

After a multi-year hiatus due to the COVID-19 pandemic, the D-Link diabetes support group has resumed in-person monthly meetings for teenagers with diabetes.

The multitude of cancer research studies being conducted at the University at Buffalo was on full display at the UB Cancer Research Consortium Symposium.

A researcher who focuses on mind-body modalities as treatments for migraine headaches was the featured speaker at the 21st annual Lawrence & Nancy Golden Memorial Lectureship on Mind-Body Medicine.  

UBMD Internal Medicine has opened Western New York’s first Long COVID Center. Funded by a grant from the Mother Cabrini Health Foundation with support from the University at Buffalo, the center is accepting all patients, whether they have insurance or not.

Clinicians treating severe obesity have a new genetic tool for predicting — and ultimately improving — bariatric surgery outcomes. 

The UB conference has become Buffalo’s primary forum for discussing, addressing and trying to mitigate the social determinants of health.

Dustin Morgan, MD, a PGY-5 chief resident in the orthopaedics residency program, won first place in the resident poster competition at the 2023 annual meeting of the NYS Society of Orthopaedic Surgeons (NYSSOS) Sept. 9 in Rochester.

Researchers have discovered how an active form of a gene present in 75% of the human population works to protect the brain against neurodegeneration. 

John “Jack” M. Sullivan, MD, PhD, professor of ophthalmology in the Jacobs School of Medicine and Biomedical Sciences, has been awarded a four-year National Eye Institute RO1 grant to continue research in RNA therapeutics.

Kenneth E. Leonard, PhD, director of UB’s Clinical and Research Institute on Addictions, has been appointed to the Program Advisory Board of the National Consortium on Alcohol and Neurodevelopment in Adolescent-Adulthood (NCANDA-A).

Treating newly diagnosed Type 1 diabetes patients with semaglutide (trade names Ozempic, Wegovy and Rybelsus) may drastically reduce or even eliminate their need for injected insulin.

The powerful 3T scanner will facilitate breakthroughs in understanding and treating MS, stroke, Alzheimer’s and other diseases.

UB researchers are unraveling the complex biological phenomena that drive our ability to detect heat and pain.

The National Eye Institute has approved additional funding for research on retinal development led by Xiuqian Mu, MD, PhD, professor of ophthalmology.

Yijun Sun, PhD, professor of microbiology and immunology, has received two large-scale R01 grants from the National Institutes of Health to study cancer evolution and progression.